Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
139115-90-5
201467-81-4
166388-57-4
172531-37-2
356046-26-9
36716-71-9 | 4-(4-Chlorophenyl)-4-hydroxycyclohexanone | AA00C99E | MFCD16251306
34329-73-2 | Methyl 3-bromo-2-oxobutanoate | AA00C9G1 | MFCD11227208
31858-65-8 | O-Desmethyl Mycophenolic Acid | AA00C9L7 | MFCD18252471
352273-66-6 | 2-(Acetylamino)-1-O-benzyl-2-deoxy-3,4-O-isopropylidene-6-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-D-galactopyranoside | AA00C9SM
38150-27-5 | 5-chloro-2-[3-(hydroxymethyl)-5-methyl-4H-1,2,4-triazol-4-yl]benzophenone | AA00C9YH | MFCD30719826
41118-21-2 | Methyl 4-oxochroman-7-carboxylate | AA00CA9W | MFCD00150335
3260-63-7 | N-Methylindoxyl acetate | AA00CAPR | MFCD00056015
33623-16-4 | 2-Methoxy-3-nitropyridin-4-amine | AA00CAZH | MFCD07437848
25717-12-8 | Benzothiazol-2-yl-o-tolyl-amine | AA00CDFI | MFCD02724568
209971-43-7 | N-(5-Iodo-pyridin-2-yl)-4-methyl-benzenesulfonamide | AA00CFU3 | MFCD09746246
